Amneal Pharmaceuticals, Inc. AMRX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s total current assets?
- Amneal Pharmaceuticals, Inc. (AMRX) reported total current assets of $1.8B in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s total current assets changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s total current assets increased by 19.0% year-over-year, from $1.51B to $1.8B.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s total current assets has grown at a 4.3% compound annual growth rate (CAGR), from $1.55B to $1.91B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.